Clinical trial
Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for…
NCT00193583 · SCRI Development Innovations, LLC, Other · Completed
Key facts
| NCT number | NCT00193583 |
|---|---|
| Title | Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors |
| Official title | A Phase I Study of Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Patients With Refractory and/or Advanced Solid Tumors |
| Lead sponsor | SCRI Development Innovations, LLC, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | Topotecan, Carboplatin |
| Enrollment | 18 |
| Start date | May 1, 2003 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | May 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: